Leukapheresis Market Size, Share & Trends Analysis Report By Product (Leukapheresis Devices, Leukapheresis Disposables), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Leukapheresis Market Size & Trends
The global leukapheresis market size was estimated at USD 191.8 million in 2023 and is projected t%li%grow at a CAGR of 10.94% from 2024 t%li%2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures and growing demand for personalized medicine are expected t%li%drive the market growth. Moreover, the increasing investments in research and development activities is further contributing t%li%the market growth.
The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected t%li%receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people finds autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors, and offers insights int%li%the causes of these diseases including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.
The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected t%li%enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimize donor discomfort, and optimize cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis t%li%retrieve mononuclear cells from pediatric and adult patients wh%li%are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated t%li%propel the market growth over the forecast period.
The shift towards personalized medicine approaches that tailor treatment strategies t%li%individual patient profiles are fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.
Global Leukapheresis Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global leukapheresis market report based on product, application, end-use, and region.
Leukapheresis Market Size & Trends
The global leukapheresis market size was estimated at USD 191.8 million in 2023 and is projected t%li%grow at a CAGR of 10.94% from 2024 t%li%2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures and growing demand for personalized medicine are expected t%li%drive the market growth. Moreover, the increasing investments in research and development activities is further contributing t%li%the market growth.
The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected t%li%receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people finds autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors, and offers insights int%li%the causes of these diseases including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.
The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected t%li%enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimize donor discomfort, and optimize cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis t%li%retrieve mononuclear cells from pediatric and adult patients wh%li%are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated t%li%propel the market growth over the forecast period.
The shift towards personalized medicine approaches that tailor treatment strategies t%li%individual patient profiles are fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.
Global Leukapheresis Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global leukapheresis market report based on product, application, end-use, and region.
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Leukapheresis Devices
- Centrifugal Devices
- Membrane Separators
- Leukapheresis Disposables
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Research Application
- Cancer Research
- Immunology Research
- Others
- Therapeutics Application
- Hematologic Disorders
- Autoimmune Diseases
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Blood Centers
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. LEUKAPHERESIS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
3.2.1.2. Technological advancements in leukapheresis procedures
3.2.1.3. Growing demand for personalized medicine
3.2.1.4. Rising investments in research& development
3.2.2. Market restraint analysis
3.2.2.1. High equipment costs
3.3. Leukapheresis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. LEUKAPHERESIS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Global Leukapheresis Market Product Movement Analysis
4.3. Global Leukapheresis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Leukapheresis Devices
4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Centrifugal Devices
4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Membrane Separators
4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Leukapheresis Disposables
4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. LEUKAPHERESIS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Segment Dashboard
5.2. Global Leukapheresis Market Application Movement Analysis
5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Research Application
5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Cancer Research
5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Immunology Research
5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Therapeutics Application
5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.2. Hematologic Disorders
5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.3. I Autoimmune Diseases
5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. LEUKAPHERESIS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Segment Dashboard
6.2. Global Leukapheresis Market End-use Movement Analysis
6.3. Global Leukapheresis Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Blood Centers
6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Pharmaceutical & Biotechnology Companies
6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Hospitals & Clinics
6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. LEUKAPHERESIS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, APPLICATION, AND END USE
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Denmark
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework
7.5.9.3. Competitive scenario
7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive scenario
7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Charles River Laboratories International, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Adacyte Therapeutics
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. AllCells, LLC
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Asahi Kasei Medical
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Haemonetics Corporation
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Macopharma
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cerus Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. SB-Kawasumi Laboratories, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. StemExpress, LLC.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Lonza Group AG
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. LEUKAPHERESIS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
3.2.1.2. Technological advancements in leukapheresis procedures
3.2.1.3. Growing demand for personalized medicine
3.2.1.4. Rising investments in research& development
3.2.2. Market restraint analysis
3.2.2.1. High equipment costs
3.3. Leukapheresis Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. LEUKAPHERESIS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Segment Dashboard
4.2. Global Leukapheresis Market Product Movement Analysis
4.3. Global Leukapheresis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Leukapheresis Devices
4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Centrifugal Devices
4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Membrane Separators
4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Leukapheresis Disposables
4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 5. LEUKAPHERESIS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Segment Dashboard
5.2. Global Leukapheresis Market Application Movement Analysis
5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Research Application
5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.2. Cancer Research
5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.3. Immunology Research
5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Therapeutics Application
5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.2. Hematologic Disorders
5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.3. I Autoimmune Diseases
5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 6. LEUKAPHERESIS MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Segment Dashboard
6.2. Global Leukapheresis Market End-use Movement Analysis
6.3. Global Leukapheresis Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Blood Centers
6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Pharmaceutical & Biotechnology Companies
6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Hospitals & Clinics
6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 7. LEUKAPHERESIS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY PRODUCT, APPLICATION, AND END USE
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive scenario
7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.9. Denmark
7.5.9.1. Key country dynamics
7.5.9.2. Regulatory framework
7.5.9.3. Competitive scenario
7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Regulatory framework
7.8.5.3. Competitive scenario
7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Charles River Laboratories International, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Adacyte Therapeutics
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. AllCells, LLC
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Asahi Kasei Medical
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Haemonetics Corporation
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Macopharma
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cerus Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. SB-Kawasumi Laboratories, Inc.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. StemExpress, LLC.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Lonza Group AG
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
LIST OF TABLES
Table 1. List of abbreviation
Table 2. Global leukapheresis market, by region, 2018 - 2030 (USD Million)
Table 3. Global leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 4. Global leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 5. Global leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 6. North America leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 7. North America leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 8. North America leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 9. North America leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 10. U.S. leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 11. U.S. leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 12. U.S. leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 13. Canada leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 14. Canada leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 15. Canada leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 16. Mexico leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 17. Mexico leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 18. Mexico leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 19. Europe leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 20. Europe leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 21. Europe leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 22. Europe leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 23. Germany leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 24. Germany leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 25. Germany leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 26. UK leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 27. UK leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 28. UK leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 29. France leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 30. France leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 31. France leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 32. Italy leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 33. Italy leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 34. Italy leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 35. Spain leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 36. Spain leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 37. Spain leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 38. Denmark leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 39. Denmark leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 40. Denmark leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 41. Sweden leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 42. Sweden leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 43. Sweden leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 44. Norway leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 45. Norway leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 46. Norway leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 49. Asia Pacific leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 50. Asia Pacific leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 51. China leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 52. China leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 53. China leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 54. Japan leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 55. Japan leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 56. Japan leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 57. India leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 58. India leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 59. India leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 60. South Korea leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 61. South Korea leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 62. South Korea leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 63. Australia leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 64. Australia leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 65. Australia leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 66. Thailand leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 67. Thailand leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 68. Thailand leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 69. Latin America leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 71. Latin America leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 72. Latin America leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 73. Brazil leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 74. Brazil leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 75. Brazil leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 76. Argentina leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 77. Argentina leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 78. Argentina leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 79. MEA leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 80. MEA leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 81. MEA leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 82. MEA leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 83. South Africa leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 84. South Africa leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 85. South Africa leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 89. UAE leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 90. UAE leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 91. UAE leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 92. Kuwait leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 93. Kuwait leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 94. Kuwait leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 1. List of abbreviation
Table 2. Global leukapheresis market, by region, 2018 - 2030 (USD Million)
Table 3. Global leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 4. Global leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 5. Global leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 6. North America leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 7. North America leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 8. North America leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 9. North America leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 10. U.S. leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 11. U.S. leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 12. U.S. leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 13. Canada leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 14. Canada leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 15. Canada leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 16. Mexico leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 17. Mexico leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 18. Mexico leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 19. Europe leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 20. Europe leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 21. Europe leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 22. Europe leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 23. Germany leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 24. Germany leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 25. Germany leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 26. UK leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 27. UK leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 28. UK leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 29. France leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 30. France leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 31. France leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 32. Italy leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 33. Italy leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 34. Italy leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 35. Spain leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 36. Spain leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 37. Spain leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 38. Denmark leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 39. Denmark leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 40. Denmark leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 41. Sweden leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 42. Sweden leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 43. Sweden leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 44. Norway leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 45. Norway leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 46. Norway leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 49. Asia Pacific leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 50. Asia Pacific leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 51. China leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 52. China leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 53. China leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 54. Japan leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 55. Japan leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 56. Japan leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 57. India leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 58. India leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 59. India leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 60. South Korea leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 61. South Korea leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 62. South Korea leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 63. Australia leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 64. Australia leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 65. Australia leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 66. Thailand leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 67. Thailand leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 68. Thailand leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 69. Latin America leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 71. Latin America leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 72. Latin America leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 73. Brazil leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 74. Brazil leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 75. Brazil leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 76. Argentina leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 77. Argentina leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 78. Argentina leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 79. MEA leukapheresis market, by country, 2018 - 2030 (USD Million)
Table 80. MEA leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 81. MEA leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 82. MEA leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 83. South Africa leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 84. South Africa leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 85. South Africa leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 89. UAE leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 90. UAE leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 91. UAE leukapheresis market, by end-use, 2018 - 2030 (USD Million)
Table 92. Kuwait leukapheresis market, by product, 2018 - 2030 (USD Million)
Table 93. Kuwait leukapheresis market, by application, 2018 - 2030 (USD Million)
Table 94. Kuwait leukapheresis market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 North America Ceramic Tiles Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Data Analysis Models
Fig. 4 Market Formulation And Validation
Fig. 5 Data Validating & Publishing
Fig. 6 Market Outlook
Fig. 7 Segmental Outlook
Fig. 8 Segmental Outlook
Fig. 9 Competitive Outlook
Fig. 10 Market Lineage Outlook, 2023 (USD Billion)
Fig. 11 Value Chain Analysis
Fig. 12 Single-Pass Digital Inkjet Tile Printer
Fig. 13 Assembly of Print Heads
Fig. 14 Sales Channel Analysis
Fig. 15 Market Dynamics
Fig. 16 Market Driver Impact Analysis
Fig. 17 Spending of U.S construction industry (USD Million)
Fig. 18 Market Restraint Impact Analysis
Fig. 19 Industry Analysis: Porter’s
Fig. 20 Industry Analysis: PESTEL by SWOT
Fig. 21 Product: Key Takeaways
Fig. 22 Product: Market Share, 2023 & 2030
Fig. 23 North America glazed ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 24 North America porcelain tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 25 North America scratch-free ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 26 North America ceramic tiles market estimates & forecasts, by other products, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 27 Application: Key Takeaways
Fig. 28 Application: Market Share, 2023 & 2030
Fig. 29 North America ceramic wall tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 30 North America ceramic floor tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 31 North America ceramic tiles market estimates & forecasts, in other applications, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 32 End-use: Key Takeaways
Fig. 33 End-use: Market Share, 2023 & 2030
Fig. 34 North America ceramic tiles market estimates & forecasts for residential, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 35 North America ceramic tiles market estimates & forecasts for commercial, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 36 Regional Outlook
Fig. 37 North America ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 38 U.S. ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 39 Canada ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 40 Mexico ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 41 Kraljic Matrix
Fig. 42 Engagement Model
Fig. 43 Sourcing Best Practices
Fig. 44 Vendor Selection Criteria
Fig. 45 Competition Categorization
Fig. 46 Company Market Positioning
Fig. 47 Strategy Mapping, 2023
Fig. 1 North America Ceramic Tiles Market Segmentation
Fig. 2 Information Procurement
Fig. 3 Data Analysis Models
Fig. 4 Market Formulation And Validation
Fig. 5 Data Validating & Publishing
Fig. 6 Market Outlook
Fig. 7 Segmental Outlook
Fig. 8 Segmental Outlook
Fig. 9 Competitive Outlook
Fig. 10 Market Lineage Outlook, 2023 (USD Billion)
Fig. 11 Value Chain Analysis
Fig. 12 Single-Pass Digital Inkjet Tile Printer
Fig. 13 Assembly of Print Heads
Fig. 14 Sales Channel Analysis
Fig. 15 Market Dynamics
Fig. 16 Market Driver Impact Analysis
Fig. 17 Spending of U.S construction industry (USD Million)
Fig. 18 Market Restraint Impact Analysis
Fig. 19 Industry Analysis: Porter’s
Fig. 20 Industry Analysis: PESTEL by SWOT
Fig. 21 Product: Key Takeaways
Fig. 22 Product: Market Share, 2023 & 2030
Fig. 23 North America glazed ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 24 North America porcelain tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 25 North America scratch-free ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 26 North America ceramic tiles market estimates & forecasts, by other products, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 27 Application: Key Takeaways
Fig. 28 Application: Market Share, 2023 & 2030
Fig. 29 North America ceramic wall tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 30 North America ceramic floor tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 31 North America ceramic tiles market estimates & forecasts, in other applications, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 32 End-use: Key Takeaways
Fig. 33 End-use: Market Share, 2023 & 2030
Fig. 34 North America ceramic tiles market estimates & forecasts for residential, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 35 North America ceramic tiles market estimates & forecasts for commercial, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 36 Regional Outlook
Fig. 37 North America ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 38 U.S. ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 39 Canada ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 40 Mexico ceramic tiles market estimates & forecasts, 2018 - 2030 (Million Square Meters) (USD Million)
Fig. 41 Kraljic Matrix
Fig. 42 Engagement Model
Fig. 43 Sourcing Best Practices
Fig. 44 Vendor Selection Criteria
Fig. 45 Competition Categorization
Fig. 46 Company Market Positioning
Fig. 47 Strategy Mapping, 2023
